Autres langues Gentian Diagnostics

Actions

GENT

NO0010748866

Marché Fermé - Oslo Bors Autres places de cotation 16:45:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
54,5 ^NOK	-0,91 %		-2,68 %	+31,33 %

28/06	Gentian Diagnostics ASA annonce que la phase d'optimisation du NT-proBNP est terminée avec succès	CI
30/04	Gentian Diagnostics ASA annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Gentian Diagnostics ASA Announces NT-proBNP successful completion of optimisation phase	28/06
Gentian Diagnostics : Groundbreaking assay development for measuring total NT-proBNP levels	28/06
Gentian Diagnostics: NT-proBNP successful completion of optimisation phase	28/06
Gentian Diagnostics : Production assistant - HQ based in Moss, Norway	13/05
Gentian Diagnostics : Application Sales Specialist (US based)	13/05
Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
Gentian Diagnostics : 30 April 2024 - Quarterly Presentation - Q1 2024	30/04
Gentian Diagnostics : 30 April 2024 - Quarterly Report - Q1 2024	30/04
Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors	29/04
Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO	29/04
Gentian Diagnostics: New acting CEO and Chairperson of the Board of Directors	29/04
Gentian Diagnostics : Scientists to Gentian’s R&D department	08/04
Gentian Diagnostics ASA Announces Resignation of Hilja Ibert as CEO, Effective on April 29, 2024	21/03
Tomas Settevik Not to Stand for Re-Election as Chairperson of Gentian Diagnostics ASA, Effective April 29, 2024	21/03
Gentian Diagnostics' CEO Resigns, Wins Recommendation to Succeed Chair	21/03
Gentian Diagnostics ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	09/02
Gentian Diagnostics Asa Announces Resignation of Frank Frantzen from the Board of Directors	18/12
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference	14/12
Gentian Diagnostics ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/10/23
Gentian Diagnostics : Sales and Application Specialist - Nordic	10/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Gentian Diagnostics

Actions

GENT

NO0010748866

Autres langues

Filtres